TARGETING DIFFUSE INTRINSIC PONTINE GLIOMA WITH IL-7Ra-ENHANCED B7-H3 (CMD03) CHIMERIC ANTIGEN RECEPTOR T CELL: PRELIMINARY RESULTS FROM PHASE 1 CLINICAL TRIAL

Authors
Category Primary study
Conference40th Annual Meeting of Society for Immunotherapy of Cancer, SITC 2025
Year 2025
This article has no abstract
Epistemonikos ID: 4927374b33d83e1177fc7ed8026c3e376e951c86
First added on: Dec 12, 2025